心率特征监测缩短新生儿重症监护病房住院时间
该研究对HeRO随机对照试验中极低出生体重(<1500 g)新生儿进行住院时间指标的回顾性分析,比较接受心率特征(HRC)监测与对照组的差异。结论认为HRC监测与极低出生体重患者死亡率降低及感染存活者住院时间缩短相关。
要点
- 其他住院时间指标有缩短趋势但未达统计学显著性。
核心结论
- HRC监测与极低出生体重患者死亡率降低相关,并与感染存活极低出生体重儿住院时间缩短相关。
研究设计与样本
- 对多中心HRC监测随机对照试验(HeRO RCT,注册号NCT00307333)中极低出生体重(<1500 g)新生儿进行住院时间指标的回顾性分析,涵盖全部患者、全部存活者及血或尿培养阳性存活者3个亚组。
主要发现
- 其他住院时间指标在HRC监测组有缩短趋势,但均未达统计学显著性。
临床怎么用
- 在极低出生体重新生儿中可考虑应用HRC监测,以辅助降低死亡风险并可能缩短感染存活者的住院时间。
局限性
- 本研究为对RCT的回顾性分析,其他住院时间指标仅见趋势而未达统计学显著性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To examine the effect of heart rate characteristics (HRC) monitoring on length of stay among very low birth weight (VLBW; <1500 g birth weight) neonates in the HeRO randomized controlled trial (RCT). STUDY DESIGN: We performed a retrospective analysis of length of stay metrics among 3 subpopulations (all patients, all survivors, and survivors with positive blood or urine cultures) enrolled in a multicenter, RCT of HRC monitoring. RESULTS: Among all patients in the RCT, infants randomized to receive HRC monitoring were more likely than controls to be discharged alive and prior to day 120 (83.6% vs 80.1%, P = .014). The postmenstrual age at discharge for survivors with positive blood or urine cultures was 3.2 days lower among infants randomized to receive HRC monitoring when compared with controls (P = .026). Although there were trends in other metrics toward reduced length of stay in HRC-monitored patients, none reached statistical significance. CONCLUSIONS: HRC monitoring is associated with reduced mortality in VLBW patients and a reduction in length of stay among infected surviving VLBW infants. TRIAL REGISTRATION: ClinicalTrials.gov: NCT00307333.
引用
- Swanson JR, King WE, Sinkin RA, et al. Neonatal Intensive Care Unit Length of Stay Reduction by Heart Rate Characteristics Monitoring. J Pediatr. 2018. PMID: 29703576. doi:10.1016/j.jpeds.2018.02.045
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。